» Articles » PMID: 19767769

Pbx1 is a Downstream Target of Evi-1 in Hematopoietic Stem/progenitors and Leukemic Cells

Overview
Journal Oncogene
Date 2009 Sep 22
PMID 19767769
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Ecotropic viral integration site-1 (Evi-1) is a nuclear transcription factor, which is essential for the proliferation/maintenance of hematopoietic stem cells (HSCs). Aberrant expression of Evi-1 has been frequently found in myeloid leukemia, and is associated with a poor patient survival. Recently, we reported candidate target genes of Evi-1 shared in HSCs and leukemic cells using gene expression profiling analysis. In this study, we identified Pbx1, a proto-oncogene in hematopoietic malignancy, as a target gene of Evi-1. Overexpression of Evi-1 increased Pbx1 expression in hematopoietic stem/progenitor cells. An analysis of the Pbx1 promoter region revealed that Evi-1 upregulates Pbx1 transcription. Furthermore, reduction of Pbx1 levels through RNAi-mediated knockdown significantly inhibited Evi-1-induced transformation. In contrast, knockdown of Pbx1 did not impair bone marrow transformation by E2A/HLF or AML1/ETO, suggesting that Pbx1 is specifically required for the maintenance of bone marrow transformation mediated by Evi-1. These results indicate that Pbx1 is a target gene of Evi-1 involved in Evi-1-mediated leukemogenesis.

Citing Articles

Clinical significance of dynamic monitoring of EVI1 gene expression in pediatric acute myeloid leukemia.

Zhang L, Li J, Wang Z, Yang L, Chen Z, Tao F BMC Pediatr. 2024; 24(1):802.

PMID: 39643863 PMC: 11622451. DOI: 10.1186/s12887-024-05243-7.


CRISPR-Cas9-mediated deletion enhancer of MECOM play a tumor suppressor role in ovarian cancer.

Chen Y, Jiang Q, Xue Y, Chen W, Hua M Funct Integr Genomics. 2024; 24(4):125.

PMID: 38995475 DOI: 10.1007/s10142-024-01399-8.


Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer.

Zeng Z, Fu M, Hu Y, Wei Y, Wei X, Luo M Mol Cancer. 2023; 22(1):172.

PMID: 37853437 PMC: 10583419. DOI: 10.1186/s12943-023-01877-w.


EVI1-mediated Programming of Normal and Malignant Hematopoiesis.

Lux S, Milsom M Hemasphere. 2023; 7(10):e959.

PMID: 37810550 PMC: 10553128. DOI: 10.1097/HS9.0000000000000959.


Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis.

Cheng C, Hong W, Li Y, Xiao X, McKay J, Han Y J Thorac Oncol. 2023; 18(8):1003-1016.

PMID: 37150255 PMC: 10435278. DOI: 10.1016/j.jtho.2023.05.001.